Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Bevacizumab in Treating Patients With Recurrent or Persistent Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Bevacizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab in Treating Patients With Angiosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2)
- Status
- COMPLETED
- Phase
- PHASE3